Tag: Khiron Life Sciences Corp.

February 20, 2020

Khiron Announces Plans to Expand Kuida® Distribution to Spain

Khiron Life Sciences (TSXV:KHRN), (OTCQB:KHRNF), (Frankfurt:A2JMZC) announced today its intent to bring the Company's Kuida® CBD brand to the Spanish...
February 14, 2020

Khiron to Participate in 3rd Annual Gravitas Growth Conference in Vancouver, BC

Khiron will be participating in the 3rd Annual Gravitas Growth Conference taking place February 20th, at the Fairmont Pacific Rim Hotel in Vancouver.
February 11, 2020

Khiron Announces Normal Course Issuer Bid

Khiron Life Sciences Corp. announces its intention to commence a normal course issuer bid through the facilities of the TSX...
February 7, 2020

Brazil Health Agency Authorizes Import of Khiron Medical Cannabis Product

Khiron announced that the Brazilian Health Regulatory Agency has authorized for Khiron medical cannabis product to be imported into Brazil.
January 14, 2020

Khiron Increases Clinical Capacity in Colombia by 75 Percent with Opening of Zerenia Integrated Medical Clinic

Khiron Life Sciences Corp. announced the opening of Zerenia, a fully integrated medical care clinic designed to meet patient health...
January 6, 2020

Khiron CEO Alvaro Torres to Present at AltaCorp/ATB 8th Annual Institutional Investor Conference

Khiron (TSXV:KHRN) CEO and Director Alvaro Torres will speak on the International Expansion panel at the AltaCorp/ATB 8th Annual Institutional...
December 30, 2019

Khiron Welcomes Colombia’s Receipt of 2020 Production Quota of 56.5 Tons of High-THC Cannabis

Khiron welcomes the Colombian government's announcement that the country has been awarded a record high quota of 21.84% of worldwide...